1. The Prophylactic Use of Bovine Colostrum in a Murine Model of TNBS-Induced Colitis
- Author
-
Iulia Elena Filipescu, Patrizia Casagrande-Proietti, Leonardo Leonardi, Anna Beatrice Casano, Giulio Curone, Alda Quattrone, Daniele Vigo, Gabriele Brecchia, Laura Menchetti, Federica Piro, Federica Riva, Giovanna Traina, Olimpia Barbato, Gabriella Guelfi, Menchetti, Laura, Curone, Giulio, Filipescu, Iulia Elena, Barbato, Olimpia, Leonardi, Leonardo, Guelfi, Gabriella, Traina, Giovanna, Casagrande-Proietti, Patrizia, Riva, Federica, Casano, Anna Beatrice, Piro, Federica, Vigo, Daniele, Quattrone, Alda, and Brecchia, Gabriele
- Subjects
medicine.medical_treatment ,animal diseases ,medicine.disease_cause ,Article ,bovine colostrum ,TNBS-induced colitis ,TLR4 ,cytokines ,microbiota ,Andrology ,Lactobacillus ,lcsh:Zoology ,medicine ,cytokine ,lcsh:QL1-991 ,Colitis ,Receptor ,Saline ,Escherichia coli ,Bifidobacterium ,lcsh:Veterinary medicine ,General Veterinary ,biology ,business.industry ,medicine.disease ,biology.organism_classification ,lcsh:SF600-1100 ,Colostrum ,TNBS-induced coliti ,Animal Science and Zoology ,business - Abstract
This study investigated the effects of a short-term administration of bovine colostrum (BC) in a TNBS model of induced colitis. Colitis was induced by TNBS treatment after seven days of BC (BC group, n = 12) or saline (control group, n = 12) administration in mice. Clinical signs, histopathological characteristics, expression levels of Toll-like receptor 4 (TLR4), pro- and anti-inflammatory cytokines, and microbial composition were assessed. BC was well tolerated and did not induce any histological damage or clinical symptoms. After TNBS treatment, the BC group showed a reduction in body weight (BW) loss compared to Control (p <, 0.05). Moreover, expression levels of TLR4 (p <, 0.01), Interleukin-1&beta, (IL-1&beta, p <, 0.001), Interleukin-8 (IL-8, 0.001), and Interleukin-10 (IL-10, 0.001) were lower in mice administered with BC. Finally, Escherichia coli were higher (p <, 0.05), while Enterococci (p <, 0.001), Lactobacillus spp. (p <, 0.001), and Bifidobacterium spp. (p <, 0.05) were lower in Control than BC group. This study confirms that pre-treatment with BC modulates the expression of genes and the count of microbes involved in the etiopathogenesis of colitis.
- Published
- 2020
- Full Text
- View/download PDF